Radiotherapy-Associated Atrial Fibrillation

Radiotherapy-associated Atrial Fibrillation: Onset Time and Frequency

Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer.

Each patient will have 12 lead ECG prior, and daily during radiotherapy.

Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation.

Inclusing Criteria:

1. Patients with radiotherapy for thoracic malignancy or breast cancer
2. Between 18-99 years-old

Exclusion Criteria:

1. Patients with history of radiotherapy
2. Patients with history of atrial fibrillation
3. Patients with pacemaker implantation

Inclusion Criteria:

• Patients with radiotherapy for thoracic malignancy or breast cancer
• Between 18-99 years-old

Exclusion Criteria:

• Patients with history of radiotherapy
• Patients with history of atrial fibrillation
• Patients with pacemaker implantation